newsfilter
← Latest News
Business Wire·

Cortexyme Presents New Data Demonstrating Atuzaginstat Disrupts Biofilms and is Efficacious in Preclinical Models of Periodontal Disease at IADR 2021

Leading drug candidate penetrates and disrupts bacterial biofilms, a key feature for efficacy in treating P. gingivalis driven disease Atuzaginstat reverses alveolar bone loss in mice after oral P. gingivalis infection at doses relevant for therapeut